help button home button
AJRCMB
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Published ahead of print on September 29, 2005, doi:10.1165/rcmb.2005-0164OC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2005-0164OCv1
34/1/108    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by West, E. E.
Right arrow Articles by McDyer, J. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by West, E. E.
Right arrow Articles by McDyer, J. F.
American Journal of Respiratory Cell and Molecular Biology. Vol. 34, pp. 108-118, 2006
© 2006 American Thoracic Society
DOI: 10.1165/rcmb.2005-0164OC

Pluripotent Allospecific CD8+ Effector T Cells Traffic to Lung in Murine Obliterative Airway Disease

Erin E. West, Tera L. Lavoie, Jonathan B. Orens, Edward S. Chen, Shui Q. Ye, Fred D. Finkelman, Joe G. N. Garcia and John F. McDyer

Department of Medicine, Division of Pulmonary and Critical Care Medicine, The Johns Hopkins University, Baltimore, Maryland; and Division of Immunology, Department of Medicine, University of Cincinnati College of Medicine, Cincinnati, Ohio

Correspondence and requests for reprints should be addressed to John F. McDyer, Johns Hopkins Allergy and Asthma Center, Johns Hopkins University, 5501 Bayview Circle, Rm 4B.74, Baltimore, MD 21224. E-mail: jmcdyer{at}jhmi.edu

Long-term success in lung transplantation is limited by obliterative bronchiolitis, whereas T cell effector mechanisms in this process remain incompletely understood. Using the mouse heterotopic allogeneic airway transplant model, we studied T cell effector responses during obliterative airways disease (OAD). Allospecific CD8+IFN-{gamma}+ T cells were detected in airway allografts, with significant coexpression of TNF-{alpha} and granzyme B. Therefore, using IFN-{gamma} as a surrogate marker, we assessed the distribution and kinetics of extragraft allo-specific T cells during OAD. Robust allospecific IFN-{gamma} was produced by draining the lymph nodes, spleen, and lung mononuclear cells from allograft, but not isograft recipients by Day 14, and significantly decreased by Day 28. Although the majority of allospecific T cells were CD8+, allospecific CD4+ T cells were also detected in these compartments, with each employing distinct allorecognition pathways. An influx of pluripotent CD8+ effector cells with a memory phenotype were detected in the lung during OAD similar to those seen in the allografts and secondary lymphoid tissue. Antibody depletion of CD8+ T cells markedly reduced airway lumen obliteration and fibrosis at Day 28. Together, these data demonstrate that allospecific CD8+ effector T cells play an important role in OAD and traffic to the lung after heterotopic airway transplant, suggesting that the lung is an important immunologic site, and perhaps a reservoir, for effector cells during the rejection process.

Key Words: effector T cells • lung allograft rejection • lung transplantation • obliterative airways disease




This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
A. Panoskaltsis-Mortari, K. V. Tram, A. P. Price, C. H. Wendt, and B. R. Blazar
A New Murine Model for Bronchiolitis Obliterans Post Bone Marrow Transplant
Am. J. Respir. Crit. Care Med., October 1, 2007; 176(7): 713 - 723.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
J. F. McDyer
Human and Murine Obliterative Bronchiolitis in Transplant
Proceedings of the ATS, January 1, 2007; 4(1): 37 - 43.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Crit. Care Med.
Copyright © 2006 American Thoracic Society.